{
    "eid": "2-s2.0-85102124477",
    "title": "Viral rebound kinetics correlate with distinct hiv antibody features",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology",
            "@code": "2404",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Antibody function",
        "Glycosylation",
        "Human immunodeficiency virus",
        "Immune activation",
        "Viral reservoir"
    ],
    "authors": [
        "Yannic C. Bartsch",
        "Carolin Loos",
        "Evan Rossignol",
        "Jesse M. Fajnzylber",
        "Dansu Yuan",
        "Anchalee Avihingsanon",
        "Sasiwimol Ubolyam",
        "Thidarat Jupimai",
        "Bernard Hirschel",
        "Jintanat Ananworanich",
        "Douglas A. Lauffenburger",
        "Jonathan Z. Li",
        "Galit Alter",
        "Boris Julg"
    ],
    "citedby-count": 7,
    "ref-count": 55,
    "ref-list": [
        "Learning from the exceptions: HIV remission in post-treatment controllers",
        "An integrated overview of HIV-1 latency",
        "Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells",
        "Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells",
        "Immune activation and HIV persistence: implications for curative approaches to HIV infection",
        "Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics",
        "The antibodiome\u2014mapping the hu-moral immune response to HIV",
        "Nonneutralizing functional antibodies: a new \u201cold\u201d paradigm for HIV vaccines",
        "Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control",
        "Infrequent re-covery of HIV from but robust exogenous infection of activated CD4(+)T cells in HIV elite controllers",
        "Dissecting pol-yclonal vaccine-induced humoral immunity against HIV using systems se-rology",
        "Glycan-based biomarkers for diagnosis of cancers and other diseases: past, present, and future",
        "Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome",
        "A novel protein glycan biomarker and future cardiovascular disease events",
        "IgG glycan patterns are associated with type 2 diabetes in independent European populations",
        "Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint",
        "CD4-guided scheduled treatment interruptions com-pared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial",
        "Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004",
        "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity",
        "Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG",
        "IgG1 Fc N-glycan galactosylation as a biomarker for immune activation",
        "Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up",
        "Natural variation in Fc glycosylation of HIV-spe-cific antibodies impacts antiviral activity",
        "Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection",
        "IP-10 is highly involved in HIV infec-tion",
        "Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction",
        "A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control",
        "HIV-1 DNA predicts disease progression and post-treatment virological control",
        "The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption",
        "A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection",
        "Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART",
        "ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia",
        "Tissue reservoirs of HIV",
        "Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic pre-dictors of HIV infection",
        "Antibody-mediated internalization of infectious HIV-1 virions differs among antibody isotypes and subclasses",
        "Cell-associated HIV RNA: a dynamic biomarker of viral persistence",
        "HIV antibody level as a marker of HIV persistence and low-level viral replication",
        "Immunological bio-markers predict HIV-1 viral rebound after treatment interruption",
        "A quantitative approach for measuring the reservoir of latent HIV-1 proviruses",
        "Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection",
        "Safety and efficacy of VRC01 broadly neutralis-ing antibodies in adults with acutely treated HIV (RV397): a phase 2, rand-omised, double-blind, placebo-controlled trial",
        "Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retrovi-ral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection",
        "Defining total-body AIDS-virus burden with implications for curative strategies",
        "High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples",
        "A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation",
        "A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis",
        "A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples",
        "A functional role for antibodies in tuberculosis",
        "Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line",
        "Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC",
        "A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor",
        "A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis",
        "HIV-1 proviral land-scapes distinguish posttreatment controllers from noncontrollers",
        "A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load",
        "Permutation tests for studying classifier per-formance"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "60022195",
            "affilname": "Massachusetts Institute of Technology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022195",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geneva",
            "@id": "60009963",
            "affilname": "H\u00f4pitaux Universitaires de Gen\u00e8ve",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009963",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Amsterdam",
            "@id": "60002483",
            "affilname": "Universiteit van Amsterdam",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002483",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": []
}